Results 271 to 280 of about 167,569 (309)
Some of the next articles are maybe not open access.

RASER angioplasty

Catheterization and Cardiovascular Interventions, 2011
AbstractThe experience with a new approach of using combined debulking technique for treating heavily calcified coronary artery lesions with both LASER and high speed rotational atherectomy, which is being labeled as RASER PCI, is described. The RASER PCI approach has been used in three different patients with severely calcified, undilatable coronary ...
openaire   +3 more sources

Carotid Angioplasty

Vascular Medicine, 1996
Aspirin and carotid endarterectomy represent the current method of prophylaxis against stroke in patients with symptomatic high grade carotid stenoses. Whilst balloon dilatation and stent placement is an accepted form of recannalization, elsewhere in the arterial circulation the technique is in its infancy within the supra-aortic vessels.
openaire   +4 more sources

Evolution of Angioplasty

1989
Angioplasty evolved through a series of very unusual ideas and their application to patients with atherosclerotic heart disease.
M. Kaltenbach, C. Vallbracht
openaire   +2 more sources

Carotid Angioplasty

Interventional Neuroradiology, 1999
Although no consensus yet exists on the ideal patient characteristics, materials, and indications for carotid angioplasty, it is clear that this procedure which is increasing in popularity will continue to do so. Until such time as the procedure is routinely approved (there are still barriers to insurance coverage for these procedures in the United ...
G, Duckwiler, Y P, Gobin, F, ViƱuela
openaire   +2 more sources

Comparison of Cutting Balloon Angioplasty and Percutaneous Balloon Angioplasty of Arteriovenous Fistula Stenosis: A Meta-Analysis and Systematic Review of Randomized Clinical Trials.

Journal of interventional cardiology, 2015
BACKGROUND Hemodialysis (HD) access failure is a common cause of increased morbidity and healthcare cost in patients with end stage renal disease (ESRD).
S. Agarwal   +9 more
semanticscholar   +1 more source

Laser Angioplasty

Cardiology Clinics, 1988
Laser technology clearly offers new approaches to the treatment of cardiovascular disease. The ability to transmit intense laser energy through optical fibers may allow precise ablation of pathologic cardiovascular tissues. This potential has stimulated extensive research on laser vaporization of atherosclerotic plaque, or laser angioplasty.
openaire   +2 more sources

Laser Angioplasty

Radiologic Clinics of North America, 1989
The current status of the use of lasers in the treatment of vascular disease, including the mechanism of laser angioplasty, is reviewed. The current clinical experience with various laser systems is discussed. Potential modifications of laser devices to improve their clinical utility are examined.
openaire   +2 more sources

Management of failed angioplasty with laser balloon angioplasty

SPIE Proceedings, 1990
Laser balloon angioplasty (LBA) is a technique for improving the post angioplasty result by the radial diffusion of continuous wave Neodymium:YAG laser energy to the arterial wall during the final inflation of percutaneous transluminal coronary angioplasty (PTCA).
Ronald D. Jenkins, J. Richard Spears
openaire   +2 more sources

Safety and feasibility of a PAclitaxel-eluting balloon angioplasty in Primary Percutaneous coronary intervention in Amsterdam (PAPPA): one-year clinical outcome of a pilot study.

EuroIntervention, 2014
AIMS In primary percutaneous coronary intervention (PPCI), stenting has been shown to reduce the need for repeat target lesion revascularisation (TLR) compared to balloon angioplasty alone, but did not result in a reduction of recurrent myocardial ...
N. Vos   +9 more
semanticscholar   +1 more source

Effects of platelet glycoprotein IIb/IIIa blockade with tirofiban on adverse cardiac events in patients with unstable angina or acute myocardial infarction undergoing coronary angioplasty. The RESTORE Investigators. Randomized Efficacy Study of Tirofiban for Outcomes and REstenosis.

Circulation, 1997
BACKGROUND Adverse cardiovascular events associated with thrombotic occlusion occur in 4% to 12.8% of patients after coronary angioplasty. Recently, potent antiplatelet agents have been used to reduce those thrombotic complications. Tirofiban is a highly
T. Investigators
semanticscholar   +1 more source

Home - About - Disclaimer - Privacy